WONDFO BIOTECH(SZ:300482) Sou Hu Cai Jing·2026-01-26 06:32Group 1 - The core point of the article is that Wanfu Biotech's stock experienced a significant increase, rising over 18% in the afternoon trading session on January 26, with a reported increase of 16.01% to 25.51 yuan per share by 1:48 PM [1][4] Group 2 - Wanfu Biotech has been focusing on AI healthcare since 2018, establishing a dual approach of "mergers and acquisitions + hospital end + C-end" to create an AI healthcare ecosystem [4] - The company has innovatively developed the "Wanfu Smart Inspection" AI platform for hospitals, which includes multiple AI applications for various testing scenarios, successfully implemented in areas such as coagulation diseases, tumors, maternal and child health, and critical conditions [4] - Future plans include increasing investments in AI through mergers and acquisitions, as well as a combination of B2B and B2C strategies, to enhance the AI ecosystem and provide more valuable medical tools and products to the market [4]